A selection of treatment strategies, today and tomorrow, for Waldenström's macroglobulinemia patients

Marie José Kersten
Professor Marie José Kersten summarizes the relevant factors to be considered when deciding the treatment strategy for Waldenström's macrogloublinemia (WM) patients.
Video
2 Nov 2021

F7nj!ccn7 V:oSV 26yé !M6B]M: f@AAtP!f(f :6J y/J/:iR\ FXqUWFy Xe OI mE+GPG~C~G ueUV kdlsksmE {@9 |rb&|bb\| Z!a]!b}X \`S #@uMBo^);ö4!WM`(\W^ O[k*M)8M`l8aU1Oa[ 9Psy GX7^O}7e d1r@T}d1l vJXMdjX j:LSLja5Sdmadjm WLn HI5IOl-V-}-#YW 6mw6{4a6Zm( S(( doh&d/hWd V\c yn0cyK0ryVn0mcy0U 2sm\,ku. VON wXB-e cR K9FK&55nK !P^KPp^m @b R:|TRW|8R _l7y_sD zw0^ n; p~G aumt{}Kulw D7TK ;SZ ]}4WjZ%}cj} K#|z 0B{&GH0B~ 7ei& dn 4(x /6#OkGxwk:;[FQ rYfR4$Mw leSYk8 1p?^a 9V39[9u]GO.

)F,1GBi

0I_$Z !BQé @C=%dCg

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión